657 related articles for article (PubMed ID: 17173891)
1. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
Chen X; Geller EB; Adler MW
Eur J Pharmacol; 2007 Feb; 557(1):32-6. PubMed ID: 17173891
[TBL] [Abstract][Full Text] [Related]
2. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ.
Mogil JS; Grisel JE; Zhangs G; Belknap JK; Grandy DK
Neurosci Lett; 1996 Aug; 214(2-3):131-4. PubMed ID: 8878101
[TBL] [Abstract][Full Text] [Related]
3. Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption.
White DA; Ballard ME; Harmon AC; Holtzman SG
Brain Res Bull; 2008 Aug; 76(6):597-604. PubMed ID: 18598850
[TBL] [Abstract][Full Text] [Related]
4. An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats.
Chen XH; Adams JU; Geller EB; DeRiel JK; Adler MW; Liu-Chen LY
Eur J Pharmacol; 1995 Feb; 275(1):105-8. PubMed ID: 7774656
[TBL] [Abstract][Full Text] [Related]
5. Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine.
Imam MZ; Kuo A; Ghassabian S; Cai Y; Qin Y; Li T; Smith MT
Eur J Pharmacol; 2020 Mar; 871():172918. PubMed ID: 31958457
[TBL] [Abstract][Full Text] [Related]
6. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
7. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
Bhargava HN; Cao YJ; Zhao GM
Brain Res; 1997 Mar; 752(1-2):234-8. PubMed ID: 9106462
[TBL] [Abstract][Full Text] [Related]
8. Effects of mu and delta opioid agonists and antagonists on affective vocal and reflexive pain responses during social stress in rats.
Vivian JA; Miczek KA
Psychopharmacology (Berl); 1998 Oct; 139(4):364-75. PubMed ID: 9809857
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
10. Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats.
Chen X; Geller EB; Rogers TJ; Adler MW
Drug Alcohol Depend; 2007 Apr; 88(1):36-41. PubMed ID: 17049756
[TBL] [Abstract][Full Text] [Related]
11. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
Zhao M; Wang JY; Jia H; Tang JS
Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
[TBL] [Abstract][Full Text] [Related]
12. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
Lohmann AB; Welch SP
Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
[TBL] [Abstract][Full Text] [Related]
13. Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin.
Chen X; McClatchy DB; Geller EB; Liu-Chen L; Tallarida RJ; Adler MW
Brain Res; 2001 Jun; 904(2):252-8. PubMed ID: 11406123
[TBL] [Abstract][Full Text] [Related]
14. Receptor-selective antagonism of opioid antinociception in female versus male rats.
Craft RM; Tseng AH; McNiel DM; Furness MS; Rice KC
Behav Pharmacol; 2001 Dec; 12(8):591-602. PubMed ID: 11856896
[TBL] [Abstract][Full Text] [Related]
15. Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse.
Suh HW; Song DK; Choi SR; Chung KM; Kim YH
Neuropeptides; 1996 Oct; 30(5):479-84. PubMed ID: 8923511
[TBL] [Abstract][Full Text] [Related]
16. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
17. Chronic sucrose intake augments antinociception induced by injections of mu but not kappa opioid receptor agonists into the periaqueductal gray matter in male and female rats.
Kanarek RB; Mandillo S; Wiatr C
Brain Res; 2001 Nov; 920(1-2):97-105. PubMed ID: 11716815
[TBL] [Abstract][Full Text] [Related]
18. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
19. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used.
Adams JU; Tallarida RJ; Geller EB; Adler MW
J Pharmacol Exp Ther; 1993 Sep; 266(3):1261-7. PubMed ID: 8396630
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats.
Steinmiller CL; Young AM
Psychopharmacology (Berl); 2008 Jan; 195(4):497-507. PubMed ID: 17882404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
